Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

Article

ESI Most Cited Paper Industry Collaboration International Collaboration

author list

  • Bachert, Claus; Han, Joseph K.; Desrosiers, Martin Y.; Gevaert, Philippe; Heffler, Enrico; Hopkins, Claire; Tversky, Jody R.; Barker, Peter; Cohen, David; Emson, Claire; Martin, Ubaldo J.; Shih, Vivian H.; Necander, Sofia; Kreindler, James L.; Jison, Maria; Werkstrom, Viktoria

publication date

  • April 1, 2022

webpage

category

keywords

  • & nbsp;IL-5 receptor
  • & nbsp;biologic
  • & nbsp;eosinophilia
  • & nbsp;intranasal corticosteroids
  • & nbsp;nasal blockage
  • & nbsp;sinonasal polyposis
  • & nbsp;type 2 inflammation
  • & nbsp;nasal polyposis

  • & nbsp;systemic corticosteroids

  • Eosinophils

start page

  • 1309

end page

  • +

volume

  • 149

issue

  • 4